Related Experiment Video
Updated: Jul 19, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Antimicrobial susceptibility of non-enterococcal intrinsic glycopeptide-resistant Gram-positive organisms
Carlos Vay1, Roxana Cittadini, Claudia Barberis
1Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Hospital de Clínicas, Universidad de Buenos Aires, Argentina, CP 1407, Buenos Aires, Argentina.
Abstract:
Non-enterococcal Gram-positive bacteria that are intrinsically vancomycin-resistant have been infrequently isolated in association with serious infections. However, well-documented infections have lately been reported with increasing frequency. Because these organisms may be pathogens, we tested the MICs of 19 antimicrobial agents by the agar dilution method for predicting susceptibility. The activity of these antimicrobial agents was assessed against 28 strains (Lactobacillus rhamnosus, 6; Lactobacillus acidophilus, 1; Lactobacillus casei, 1; Lactobacillus fermentum, 2; Lactobacillus brevis, 1; Lactobacillus plantarum, 1; Weissella confusa, 2; Leuconostoc mesenteroides, 7; Leuconostoc lactis, 4; Pediococcus acidilactici, 2; Pediococcus pentosaceus, 1), isolated from clinical specimens in an Argentinian university hospital from 1997 to 2003. The MICs of penicillin for 67% of the Lactobacillus strains and 100% of the Leuconostoc spp. and Pediococcus spp. strains tested were in the 0.25-2 microg/mL range. Erythromycin was the most active antimicrobial overall. Multiresistance was observed in 2 strains (Lactobacillus rhamnosus, 1; Lactobacillus plantarum, 1).
Insights
Intrinsically vancomycin-resistant, non-enterococcal Gram-positive bacteria are increasingly linked to serious infections. This study evaluated antimicrobial susceptibility for these emerging pathogens, finding erythromycin most effective overall.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Non-enterococcal Gram-positive bacteria intrinsically resistant to vancomycin are emerging pathogens.
- Documented infections caused by these bacteria are increasing in frequency.
- Understanding their antimicrobial susceptibility is crucial for effective treatment.
Purpose of the Study:
- To determine the in vitro antimicrobial susceptibility of clinically relevant, intrinsically vancomycin-resistant, non-enterococcal Gram-positive bacteria.
- To identify potential therapeutic agents for infections caused by these organisms.
Main Methods:
- Minimum Inhibitory Concentrations (MICs) were determined for 19 antimicrobial agents using the agar dilution method.
- Testing was performed on 28 bacterial strains isolated from clinical specimens between 1997 and 2003.
- Bacterial species included Lactobacillus, Weissella, Leuconostoc, and Pediococcus.
Main Results:
- Penicillin showed limited activity, with high MICs observed for most Leuconostoc and Pediococcus strains.
- Erythromycin demonstrated the broadest activity against the tested strains.
- Multidrug resistance was identified in two strains: Lactobacillus rhamnosus and Lactobacillus plantarum.
Conclusions:
- Erythromycin is a promising agent for treating infections caused by these intrinsically vancomycin-resistant bacteria.
- The emergence of multidrug resistance highlights the need for ongoing surveillance and susceptibility testing.
- These bacteria should be considered potential pathogens in clinical settings.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
Bacterial Cell Wall
Development of Antibiotic Resistance